Steward Partners Investment Advisory’s 9 Meters Biopharma NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,117
| Closed | -$13 | – | 3633 |
|
|
2023
Q3 | $13 | Hold |
1,117
| – | – | ﹤0.01% | 3365 |
|
|
2023
Q2 | $751 | Hold |
1,117
| – | – | ﹤0.01% | 3160 |
|
|
2023
Q1 | $1.55K | Hold |
1,117
| – | – | ﹤0.01% | 3065 |
|
|
2022
Q4 | $1.41K | Hold |
1,117
| – | – | ﹤0.01% | 3086 |
|
|
2022
Q3 | $5K | Hold |
1,117
| – | – | ﹤0.01% | 2804 |
|
|
2022
Q2 | $6K | Hold |
1,117
| – | – | ﹤0.01% | 2733 |
|
|
2022
Q1 | $13K | Hold |
1,117
| – | – | ﹤0.01% | 2572 |
|
|
2021
Q4 | $22K | Hold |
1,117
| – | – | ﹤0.01% | 2288 |
|
|
2021
Q3 | $29K | Hold |
1,117
| – | – | ﹤0.01% | 2164 |
|
|
2021
Q2 | $25K | Hold |
1,117
| – | – | ﹤0.01% | 4737 |
|
|
2021
Q1 | $26.1K | Sell |
1,117
-600
| -35% | -$18.4K | ﹤0.01% | 2345 |
|
|
2020
Q4 | $29K | Hold |
1,717
| – | – | ﹤0.01% | 1933 |
|
|
2020
Q3 | $28K | Buy |
1,717
+1,521
| +776% | +$18.4K | ﹤0.01% | 1766 |
|
|
2020
Q2 | $2K | Buy |
+196
| New | +$2.21K | ﹤0.01% | 2517 |
|
Steward Partners Investment Advisory's NMTR Position: Q4 2023 in Review
Steward Partners Investment Advisory sold out of 9 Meters Biopharma (NMTR) in Q4 2023, closing a stake of 1,117 shares — an estimated $13 sold.
Steward Partners Investment Advisory first reported a position in NMTR in Q2 2020 and held it in 14 quarters. The position peaked at $29K in Q3 2021. 1 fund tracked by Wall St. Rank holds NMTR as of Q4 2023.
- Steward Partners Investment Advisory reported no remaining 9 Meters Biopharma position as of Q4 2023 after selling out during the quarter.
- Steward Partners Investment Advisory sold 1,117 9 Meters Biopharma shares in Q4 2023, an estimated $13.
- Steward Partners Investment Advisory first reported a position in 9 Meters Biopharma in Q2 2020 and held it in 14 quarters.
- Steward Partners Investment Advisory's 9 Meters Biopharma position peaked at $29K in Q3 2021.
- 1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2023.
Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.